Products

PRODUCTS. HEADER IMAGE

Decoding the host immune response into simple
diagnostic insights

​​Timely assessment of patients presenting with infection in the Emergency Department improves outcomes, patient management, and antibiotic stewardship while reducing hospital costs. At MeMed, we decode the body’s complex host response to provide clinicians with actionable insights that improve patient care.

The FDA-cleared and CE-Marked MeMed BV® accurately differentiates bacterial from viral infection within 15 minutes from serum or venous whole blood.* MeMed’s tests run on the MeMed Key®, an FDA-cleared, compact immunoassay platform that delivers quick and accurate results, where and when it actually matters.

Additional diagnostic applications, focused on critical, unmet needs in healthcare, are currently in development, all designed to support clinicians in making informed and timely decisions.

Decoding
KEY_HEADER-IMAGE

MeMed Key

home banner

MeMed BV

15 mins

Designed to deliver results in just 15 minutes from serum or venouse whole blood.*

*MeMed BV on venous whole blood is 510K cleared. Currently available only for the US market.
MeMed BV and MeMed Key are FDA, CE-IVD and AMAR cleared and available in the US, EU, and Israel.